Concentric Capital Strategies »

Tg Therapeutics shares owned by Concentric Capital Strategies

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Concentric Capital Strategies from 13F filings

Historical chart of Concentric Capital Strategies investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Concentric Capital Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Concentric Capital Strategies

Quarter filed Position value Share count Share price at filing
2024-06-30 $753k 42k 17.79
2024-03-31 $579k 38k 15.21

More positions owned by Concentric Capital Strategies

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Raytheon Technologies Corp Call Option (RTX)
Advanced Micro Devices (AMD)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Deere & Company Put Option (DE)
Broadcom (AVGO)
Uber Technologies (UBER)
Meta Platforms Cl A (META)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Adobe Systems Incorporated (ADBE)
Barclays Bank Ipth Sr B S&p (VXX)
Spotify Technology S A SHS (SPOT)

View all positions for Concentric Capital Strategies

Top funds holding Tg Therapeutics

Vanguard Group
BlackRock
State Street Corporation
Soleus Capital Management
Pictet Asset Management Holding SA
Geode Capital Management
Wellington Management Company
Deep Track Capital
Susquehanna International
Citadel Advisors
Opaleye Management
Goldman Sachs Group
Bank of America Corporation
Marshall Wace
Sofinnova Ventures

View all funds holding Tg Therapeutics